
Lucy Chapman
Articles
-
2 weeks ago |
ionanalytics.com | Laura Larghi |Lucy Chapman
News (Intelligence) Veltris is in talks with acquisition candidates and aims to close three to five add-on deals within the next 18 months, CEO Hiral Chandrana said. Backed by Trive Capital and BayLink Capital, the Milpitas, California-headquartered company provides digital product engineering services in the healthcare, communications and manufacturing sectors.
-
1 month ago |
ionanalytics.com | Laura Larghi |Lucy Chapman
News (Intelligence) ZEDEDA, a specialist in edge management and orchestration, is interested in strategic investors to accelerate its expansion in new verticals and geographies, founder and CEO Said Ouissal told Mergermarket. The goal is to strengthen the company’s presence in the sectors of telecommunications, especially, satellite, and healthcare this year and in robotics next year, the CEO said.
-
2 months ago |
ionanalytics.com | Taku Dzimwasha |Raj Saiya |Lucy Chapman
Data Insight Sector’s defensive nature attracts investors amid market volatilityFollow-ons to drive healthcare ECM volumes, with Haleon and Galderma stake sales expectedHealthcare ECM volumes in EMEA reached their highest levels in a decade last year, with the IPO of Galderma Group AG [SIX:GALD] and subsequent stake sales in the firm, along with selldowns in Haleon [LON:HLN], lifting deal volumes to USD 23.1bn in 2024, according to Dealogic data.
-
Jan 23, 2025 |
ionanalytics.com | Luuk de Klein |Tono Gil |John West |Lucy Chapman
The sudden replacement of Competition and Markets Authority (CMA) Chair Markus Bokkerink as part of the UK government’s “growth agenda” has taken the antitrust community by surprise, and raises questions as to how the CMA may change its regulatory approach.
-
Jan 21, 2025 |
ionanalytics.com | Christel Thunell |Lucy Chapman
News (Intelligence) BioMerieux [EPA:BIM], a French in vitro diagnostics company, is keen to make more acquisitions and has financial headroom of EUR 3bn-EUR 4bn for M&A, CEO Pierre Boulud said. The EUR 12.9bn market-cap company has a low debt level and is cashflow generating, so it can finance acquisitions relatively easily, Boulud told this news service on the sidelines of the J.P. Morgan Healthcare Conference in San Francisco last week.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →